HANGZHOU, China, July 8, 2026 /PRNewswire/ -- On July 8, the study of Betta's ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ALK-positive non-small cell lung cancer (NSCLC), known as the ELEVATE study, was published online in full in The New England...
Hence then, the article about groundbreaking achievement study of ensartinib as postoperative adjuvant therapy published in the new england journal of medicine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine )
Also on site :
- LIVE: Watch friends and family cross the 2026 Chicago Marathon finish line
- In the 1940s, Howard Hughes bought the peak next to the Hollywood Sign to build a house for Ginger Rogers; in 2010 more than 100 acres of it became part of Griffith Park
- Gardeners Say You Can Still Plant These 8 Vegetables in November—With the Right Conditions for a Future Harvest